5 items3 sources1 stocks
Seeking Alpha-Nov 11, 11:02 AM
MaxCyte outlines at least $34.5M 2026 revenue as it plans Akron Bio deal to accelerate profitability
MaxCyte outlines at least $34.5M 2026 revenue as it plans Akron Bio deal to accelerate profitability(摘要待生成)
Investing.com-Nov 19, 09:16 AM
Maxcyte CEO Masoud Maher buys $120,780 in company stock
Maxcyte CEO Masoud Maher buys $120,780 in company stock(摘要待生成)
The Motley Fool-Nov 11, 04:55 AM
MaxCyte (MXCT) Q3 2026 Earnings Call Transcript
MaxCyte (MXCT) Q3 2026 Earnings Call Transcript(摘要待生成)
Seeking Alpha-Nov 10, 05:40 PM
MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock
MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock(摘要待生成)
Investing.com-Nov 11, 10:19 PM
MaxCyte at Stifel 2026 Healthcare Conference: Akron deal lifts outlook
MaxCyte at Stifel 2026 Healthcare Conference: Akron deal lifts outlook(摘要待生成)
MXCThealthcare